TY - JOUR
T1 - Diabetic nephropathy
T2 - Mechanisms of renal disease progression
AU - Kanwar, Yashpal S.
AU - Wada, Jun
AU - Sun, Lin
AU - Xie, Ping
AU - Wallner, Elisabeth I.
AU - Chen, Sheldon
AU - Chugh, Sumant
AU - Danesh, Farhad R.
N1 - Funding Information:
Supported by NIH grants DK28492 and DK60635.
PY - 2008/1
Y1 - 2008/1
N2 - Diabetic nephropathy is characterized by excessive amassing of extracellular matrix (ECM) with thickening of glomerular and tubular basement membranes and increased amount of mesangial matrix, which ultimately progress to glomerulosclerosis and tubulo-interstitial fibrosis. In view of this outcome, it would mean that all the kidney cellular elements, i.e., glomerular endothelia, mesangial cells, podocytes, and tubular epithelia, are targets of hyperglycemic injury. Conceivably, high glucose activates various pathways via similar mechanisms in different cell types of the kidney except for minor exceptions that are related to the selective expression of a given molecule in a particular renal compartment. To begin with, there is an obligatory excessive channeling of glucose intermediaries into various metabolic pathways with generation of advanced glycation products (AGEs), activation of protein kinase C (PKC), increased expression of transforming growth factor-β (TGF-β), GTP-binding proteins, and generation of reactive oxygen species (ROS). The ROS seem to be the common denominator in various pathways and are central to the pathogenesis of hyperglycemic injury. In addition, there are marked alterations in intraglomerular hemodynamics, i.e., hyperfiltration, and this along with metabolic derangements adversely compounds the hyperglycemia-induced injury. Here, the information compiled under various subtitles of this article is derived from an enormous amount of data summarized in several excellent literature reviews, and thus their further reading is suggested to gain in-depth knowledge of each of the subject matter.
AB - Diabetic nephropathy is characterized by excessive amassing of extracellular matrix (ECM) with thickening of glomerular and tubular basement membranes and increased amount of mesangial matrix, which ultimately progress to glomerulosclerosis and tubulo-interstitial fibrosis. In view of this outcome, it would mean that all the kidney cellular elements, i.e., glomerular endothelia, mesangial cells, podocytes, and tubular epithelia, are targets of hyperglycemic injury. Conceivably, high glucose activates various pathways via similar mechanisms in different cell types of the kidney except for minor exceptions that are related to the selective expression of a given molecule in a particular renal compartment. To begin with, there is an obligatory excessive channeling of glucose intermediaries into various metabolic pathways with generation of advanced glycation products (AGEs), activation of protein kinase C (PKC), increased expression of transforming growth factor-β (TGF-β), GTP-binding proteins, and generation of reactive oxygen species (ROS). The ROS seem to be the common denominator in various pathways and are central to the pathogenesis of hyperglycemic injury. In addition, there are marked alterations in intraglomerular hemodynamics, i.e., hyperfiltration, and this along with metabolic derangements adversely compounds the hyperglycemia-induced injury. Here, the information compiled under various subtitles of this article is derived from an enormous amount of data summarized in several excellent literature reviews, and thus their further reading is suggested to gain in-depth knowledge of each of the subject matter.
KW - Advance glycation products
KW - GTP binding proteins
KW - Hyperglycemia
KW - Hypertension
KW - Protein kinase C
KW - Reactive oxygen species
UR - http://www.scopus.com/inward/record.url?scp=37549035027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=37549035027&partnerID=8YFLogxK
U2 - 10.3181/0705-MR-134
DO - 10.3181/0705-MR-134
M3 - Short survey
C2 - 18156300
AN - SCOPUS:37549035027
SN - 1535-3702
VL - 233
SP - 4
EP - 11
JO - Experimental Biology and Medicine
JF - Experimental Biology and Medicine
IS - 1
ER -